Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
AUB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
seekingalpha.com
6 hours ago
businesswire.com
6 hours ago
seekingalpha.com
9 hours ago
zacks.com
9 hours ago
seekingalpha.com
10 hours ago
seekingalpha.com
17 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
+8%
0.8
vs 0.74
Q4.23
-13%
0.78
vs 0.9
Q1.24
+3%
0.65
vs 0.63
Q2.24
-15%
0.63
vs 0.74
Q3.24
+4%
0.83
vs 0.8
Q4.24
-14%
0.67
vs 0.78
Q1.25
-12%
0.57
vs 0.65
Q2.25
+51%
0.95
vs 0.63
Q3.25
+2%
0.85
vs 0.83
Q4.25
+28%
0.86
vs 0.67
Sales Growth
YoY
Current
Estimates
Q3.23
+40%
272.9M vs 195.2M
Q4.23
+27%
288.4M vs 226.6M
Q1.24
+27%
287.1M vs 225.6M
Q2.24
+36%
343.4M vs 252.8M
Q3.24
+31%
357.4M vs 272.9M
Q4.24
+24%
358.5M vs 288.4M
Q1.25
+16%
333.8M vs 287.1M
Q2.25
+72%
590.6M vs 343.4M
Q3.25
+6%
378M vs 357.4M
Q4.25
+7%
382.3M vs 358.5M
Return on Equity
QoQ
Q1.23
+1%
0.01
vs 0.03
Q2.23
+2%
0.02
vs 0.01
Q3.23
+2%
0.02
vs 0.02
Q4.23
+2%
0.02
vs 0.02
Q1.24
+2%
0.02
vs 0.02
Q2.24
+1%
0.01
vs 0.02
Q3.24
+2%
0.02
vs 0.01
Q4.24
+2%
0.02
vs 0.02
Q1.25
+2%
0.02
vs 0.02
Q2.25
+0%
0
vs 0.02
Institutionnal Ownership
QoQ
Q1.23
250
250
vs 255
-2%
Q2.23
228
228
vs 250
-9%
Q3.23
247
247
vs 228
8%
Q4.23
254
254
vs 247
3%
Q1.24
275
275
vs 254
8%
Q2.24
277
277
vs 275
1%
Q3.24
305
305
vs 277
10%
Q4.24
341
341
vs 305
12%
Q1.25
357
357
vs 341
5%
Q2.25
374
374
vs 357
5%
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
42.00(19.25%)
Number of analyst
1
Last analyst upgrade/downgrade
Raymond James
upgradePrevious: Not converted
2025-06-10
Now: Strong Buy
Jefferies
initialisePrevious: Not converted
2025-05-20
Now: Buy
Hovde Group
initialisePrevious: Not converted
2022-11-29
Now: Outperform
Keefe, Bruyette & Woods
upgradePrevious: Not converted
2022-04-22
Now: Outperform
Relative Strength
AUB
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|